The store will not work correctly when cookies are disabled.
Biological Data
|
Biological description
|
Calmodulin (CaM) antagonist. Inhibits calmodulin-dependent phosphodiesterase (IC50 = 0.15 µM). Antagonises Ca2+-transporting ATPase calmodulin-induced activation (IC50 = 0.35 µM). Inhibits adenylyl cyclase, soluble fusion protein, ACIX and ACV-ACII fusion proteins. Blocks L-type calcium channels as well as voltage-dependent Na+ and K+ channel currents; increases intracellular calcium. Shows cytotoxic and apoptotic effects. |
Solubility & Handling
|
Storage instructions
|
+4°C |
|
Solubility overview
|
Soluble in DMSO (100mM) or ethanol (100mM) |
|
Important
|
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use. |
Chemical Data
|
Chemical name
|
1-[Bis(4-chlorophenyl)methyl]-3-[2- (2,4-dichlorophenyl)-2-(2,4-dichlorobenzyloxy)ethyl]-1H-imidazolium chloride |
|
Chemical structure
|
|
|
Molecular Formula
|
C31H23Cl7N2O |
|
PubChem identifier
|
644274 |
|
SMILES
|
C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)N3C=C[N+](=C3)CC(C4=C(C=C(C=C4)Cl)Cl)OCC5=C(C=C(C=C5)Cl)Cl)Cl.[Cl-] |
|
InChiKey
|
YGEIMSMISRCBFF-UHFFFAOYSA-M |
References for Calmidazolium Chloride
References are publications that support the biological activity of the product
-
Cardiotoxicity of calmidazolium chloride is attributed to calcium aggravation, oxidative and nitrosative stress, and apoptosis.
Kumar S et al (2009)
Free Radic Biol Med 47(6) : 699-709.
-
Small ligands modulating the activity of mammalian adenylyl cyclases: a novel mode of inhibition by calmidazolium.
Haunsø A et al (2003)
Mol Pharmacol 63(3) : 624-31.
-
Comparison of the calmodulin antagonists compound 48/80 and calmidazolium.
Gietzen K (1983)
Biochem J 216(3) : 611-6.
Calmodulin (CaM) antagonist